Learn about the connection between Crohn’s disease and night sweats, their possible causes, and get practical tips from ...

Opioids After Hospital Discharge May Worsen IBD Outcomes Patients with IBD who are prescribed opioids within a week of discharge from an emergency department or hospital are more likely to have poor ...

Early Anti-TNF Treatment Cost-Effective in Crohn’s Disease For patients newly diagnosed with Crohn’s disease, initiating anti-TNF therapy early led to better outcomes and lower overall costs than ...

MASLD affects more than 1 in 4 individuals with IBD and is most prevalent among adults, men, and individuals living in certain geographic regions.

Women with inflammatory bowel disease (IBD) face increased pregnancy risks, often leading to confusion and fear. UCSF’s PIANO ...

The iSNP systems genomics pipeline models how non-coding SNPs cumulatively impact cellular signalling and gene regulatory networks, revealing patient-specific mechanisms linking disease-associated ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

Please provide your email address to receive an email when new articles are posted on . Low- and high-human touch interventions improved behavioral health and symptom severity for patients with IBD, ...

Inflammatory bowel disease (IBD) in children and adolescents represents a rapidly growing field of research within pediatric gastroenterology. Over the past ...

VANCOUVER, BC, Oct. 29, 2025 /CNW/ - VVT Med Inc. (TSXV: VVTM) (the "Company" or "VVT Med"), a manufacturer of next-generation, minimally-invasive varicose vein treatments, is pleased to announce an ...

Infliximab biosimilar CT-P13 is noninferior to originator infliximab across long-term clinical outcomes, including treatment failure and steroid dependence.